Showing results (31-40 of 93) with videos related to
Sort By:
Pageof 10
Journal of the American College of Cardiology|January 5, 2002
Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarctionMartine Clozel, Changbin Qiu, Chang-Shen Qiu, et al.Journal of Hypertension|January 22, 2005
Position of Src tyrosine kinases in the interaction between angiotensin II and endothelin in in vivo vascular protein synthesisPierre Beaucage, Marc Iglarz, Marc Servant, et al.Current Hypertension Reports|January 16, 2002
Genetic determinants of vascular reactivityDaniel Henrion, Joelle Benessiano, Marc Iglarz, et al.The Journal of Pharmacology and Experimental Therapeutics|August 25, 2012
Differential effects of Selexipag [corrected] and prostacyclin analogs in rat pulmonary arteryKeith Morrison, Rolf Studer, Roland Ernst, et al.Journal of Cardiovascular Pharmacology|August 1, 2015
Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary HypertensionMarc Iglarz, Kyle Landskroner, Yasmina Bauer, et al.Bioorganic & Medicinal Chemistry Letters|March 6, 2003
The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonistsMartin H Bolli, Christoph Boss, Martine Clozel, et al.Hypertension (Dallas, Tex. : 1979)|July 23, 2003
Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertensionErnesto L Schiffrin, Farhad Amiri, Karim Benkirane, et al.Clinical Pharmacology and Therapeutics|April 17, 2002
In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburidePaul L M van Giersbergen, Alexander Treiber, Martine Clozel, et al.Life Sciences|March 16, 2016
Endothelin receptor antagonist macitentan or deletion of mouse mast cell protease 4 delays lesion development in atherosclerotic miceMartin Houde, Louisane Desbiens, Adel Schwertani, et al.American Journal of Hypertension|July 13, 2004
Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension systemMarc Iglarz, Rhian M Touyz, Emilie C Viel, et al.Pageof 10